AR034767A1 - Combinacion de principios activos para la terapia medicinal de la dependencia a la nicotina. - Google Patents

Combinacion de principios activos para la terapia medicinal de la dependencia a la nicotina.

Info

Publication number
AR034767A1
AR034767A1 ARP020102603A ARP020102603A AR034767A1 AR 034767 A1 AR034767 A1 AR 034767A1 AR P020102603 A ARP020102603 A AR P020102603A AR P020102603 A ARP020102603 A AR P020102603A AR 034767 A1 AR034767 A1 AR 034767A1
Authority
AR
Argentina
Prior art keywords
combination
active principles
medicinal therapy
nicotine dependency
medicinal
Prior art date
Application number
ARP020102603A
Other languages
English (en)
Inventor
Klaus Opitz
Joachim Moormann
Hermann Mucke
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Publication of AR034767A1 publication Critical patent/AR034767A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Abstract

Una combinación de principios activos constituida a menos por un modulador del sistema colinérgico y al menos una sustancia moduladora del sistema receptor de opioides para la terapia medicinal de la dependencia de la nicotina.
ARP020102603A 2001-07-12 2002-07-12 Combinacion de principios activos para la terapia medicinal de la dependencia a la nicotina. AR034767A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10134038A DE10134038A1 (de) 2001-07-12 2001-07-12 Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit

Publications (1)

Publication Number Publication Date
AR034767A1 true AR034767A1 (es) 2004-03-17

Family

ID=7691630

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020102603A AR034767A1 (es) 2001-07-12 2002-07-12 Combinacion de principios activos para la terapia medicinal de la dependencia a la nicotina.

Country Status (28)

Country Link
US (1) US20040167145A1 (es)
EP (1) EP1404341B1 (es)
JP (1) JP2005502633A (es)
KR (1) KR20040013143A (es)
CN (1) CN1527712A (es)
AR (1) AR034767A1 (es)
AT (1) ATE340576T1 (es)
AU (1) AU2002354856B2 (es)
BR (1) BR0211323A (es)
CA (1) CA2452432C (es)
CZ (1) CZ301204B6 (es)
DE (2) DE10134038A1 (es)
DK (1) DK1404341T3 (es)
EA (1) EA007628B1 (es)
ES (1) ES2274064T3 (es)
HK (1) HK1063159A1 (es)
HU (1) HUP0401013A3 (es)
IL (2) IL159789A0 (es)
MX (1) MXPA04000344A (es)
MY (1) MY131858A (es)
NO (1) NO20040119L (es)
NZ (1) NZ530512A (es)
PL (1) PL367779A1 (es)
PT (1) PT1404341E (es)
SK (1) SK112004A3 (es)
UA (1) UA79752C2 (es)
WO (1) WO2003007966A1 (es)
ZA (1) ZA200400305B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10338544B4 (de) * 2003-08-19 2017-08-31 Janssen Pharmaceutica N.V. Buccale Formulierungen des Galanthamins und deren Anwendungen
DE10354893B4 (de) * 2003-11-24 2011-03-10 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen
CL2008003507A1 (es) 2007-11-26 2009-11-27 Neuroderm Ltd Composicion farmaceutica que comprende nicotina y un inhibidor de la desensibilizacion del receptor de acetilcolina nicotinico (nachr) opipramol; kit farmaceutico; dispositivo medico; y uso para tratar una enfermedad o trastorno del sistema nervioso central o periferico.
DE102007058504A1 (de) * 2007-12-05 2009-07-09 Acino Ag Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR)

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US4573995A (en) * 1984-10-09 1986-03-04 Alza Corporation Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
DE3843239C1 (es) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
US5519017A (en) * 1990-03-29 1996-05-21 Lts Lohmann Therapie-Systeme Gmbh + Co. Kg Pharmaceutic formulation for the treatment of alcoholism
DE4010079A1 (de) * 1990-03-29 1991-10-02 Lohmann Therapie Syst Lts Pharmazeutische formulierung zur behandlung des alkoholismus
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
DE4301782C1 (de) * 1993-01-23 1994-08-25 Lohmann Therapie Syst Lts Verwendung von Galanthamin zur Behandlung der Nicotinabhängigkeit
EP0787115B1 (de) * 1994-10-21 2000-01-05 Sanochemia Pharmazeutika AG VERFAHREN ZUM HERSTELLEN VON DERIVATEN DES 4a,5,9,10,11,12,-HEXAHYDRO-6H-BENZOFURO[3a,3,2-ef][2]BENZAZEPINS
DE19509663A1 (de) * 1995-03-17 1996-09-19 Lohmann Therapie Syst Lts Verfahren zur Isolierung von Galanthamin
GB9514821D0 (en) * 1995-07-19 1995-09-20 Sod Conseils Rech Applic Galanthamine derivatives
WO1997018781A1 (en) * 1995-11-20 1997-05-29 University Of Miami Method of treating nicotine dependence
EP0828489A4 (en) * 1996-03-13 2001-04-04 Univ Yale Smoking cessation treatment using naltrexone and related compounds
AT403803B (de) * 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
US5965567A (en) * 1997-07-15 1999-10-12 Albany Medical College Method for treating nicotine addiction
SI1140105T1 (en) * 1998-12-24 2004-04-30 Janssen Pharmaceutica N.V. Controlled release galantamine composition
DE19906979B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit
DE19906978B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
ES2222227T3 (es) * 1999-08-13 2005-02-01 Southern Research Institute Piridomorfinanos y su utilizacion.
EP2311463A1 (en) * 1999-12-10 2011-04-20 Bonnie M. Davis Analogs of galanthamine and lycoramine as modulators of nicotinic receptors
DE10129265A1 (de) * 2001-06-18 2003-01-02 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie

Also Published As

Publication number Publication date
CA2452432A1 (en) 2003-01-30
IL159789A0 (en) 2004-06-20
AU2002354856B2 (en) 2007-05-31
IL159789A (en) 2008-07-08
DE50208267D1 (de) 2006-11-09
CA2452432C (en) 2009-09-01
NO20040119L (no) 2004-01-30
PL367779A1 (en) 2005-03-07
HUP0401013A3 (en) 2011-03-28
HUP0401013A2 (hu) 2004-08-30
KR20040013143A (ko) 2004-02-11
EP1404341B1 (de) 2006-09-27
DK1404341T3 (da) 2007-02-05
NZ530512A (en) 2007-09-28
WO2003007966A1 (de) 2003-01-30
MY131858A (en) 2007-09-28
EP1404341A1 (de) 2004-04-07
SK112004A3 (en) 2004-06-08
ZA200400305B (en) 2004-05-24
JP2005502633A (ja) 2005-01-27
BR0211323A (pt) 2004-11-30
CN1527712A (zh) 2004-09-08
CZ301204B6 (cs) 2009-12-09
EA200400116A1 (ru) 2004-08-26
ES2274064T3 (es) 2007-05-16
PT1404341E (pt) 2007-01-31
DE10134038A1 (de) 2003-02-06
ATE340576T1 (de) 2006-10-15
EA007628B1 (ru) 2006-12-29
US20040167145A1 (en) 2004-08-26
CZ200419A3 (cs) 2004-05-12
HK1063159A1 (en) 2004-12-17
UA79752C2 (en) 2007-07-25
MXPA04000344A (es) 2004-05-04

Similar Documents

Publication Publication Date Title
ES2138271T3 (es) Compuestos de 6-dimetil-amino-metil-1-fenil-ciclohexano como principio activo farmaceutico.
CY1107675T1 (el) Φαρμακευτικα αλατα τραμαδολης
PT893992E (pt) Formas de dosagem oral de desintegracao rapida
FI954990A (fi) Aktiiviainetta sisältävä transdermaalinen valmiste
AR032293A1 (es) Estuche farmaceutico
ATE318590T1 (de) Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen
EE9900288A (et) Peroraalselt manustatava farmatseutilise kompositsiooni kasutamine meeste erektiilse talitlushäire raviks ettenähtud ravimi valmistamiseks
DK0994710T3 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzhydrylpiperazin og en cyclodextrin
ES2195638T3 (es) Preparaciones de combinaciones farmaceuticas en forma solida de dosificacion que contienen cardevilol e hidroclorotiazida.
EE200000466A (et) Omeprasooli mikrograanulid, nende valmistamismeetod ja farmatseutilised preparaadid
AR034493A1 (es) Combinacion de principios activos para el tratamiento medico de toxicomanias.
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
ES2166988T3 (es) Terapia de administracion uniforme de farmacos.
NO20004419D0 (no) Ny anvendelse
DE69716469D1 (de) Pharmazeutische zusammensetzung enthaltend ein osteogenese foerderndes mittel und ein polyethylen-glycol
ATE308328T1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
BR9802537A (pt) Método para anestesiar um paciente humano antes de cirurgias de porte dose unitária e sistema farmacêutico para administração
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
ATE464878T1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
DE69934689D1 (de) Verwendung der protein-kinase-c-epsilon-inhibitoren zur behandlung von schmerzen
ES2171669T3 (es) Composicion farmaceutica que contiene hidrocloruro de tiagabina y su procedimiento de preparacion.
AR034767A1 (es) Combinacion de principios activos para la terapia medicinal de la dependencia a la nicotina.
ATE280575T1 (de) Transdermales therapeutisches system zur anwendung von candesartan
AR042308A1 (es) Medicamento de administracion transdermica y transmucosica con absorcion mejorada de principios activos
ATE487492T1 (de) Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit

Legal Events

Date Code Title Description
FB Suspension of granting procedure